Arecor Therapeutics (AREC)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

43.00p
   
  • Change Today:
      1.50p
  • 52 Week High: 160.00
  • 52 Week Low: 38.00
  • Currency: UK Pounds
  • Shares Issued: 37.76m
  • Volume: 12,395
  • Market Cap: £16.24m

AREC Overview

Arecor is a globally focused biopharmaceutical company that is targeting improving patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying the Group's innovative proprietary formulation technology platform, Arestat™, the Group is developing an internal portfolio of proprietary products, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of their partners' therapeutic products, supported by an extensive patent portfolio.
Competitors: Yourgene Health

Key Personnel

CEO: Sarah Jennifer Howell
CFO: David Ellam
Independent Non-Executive Director: Christine Helen Soden
Independent Non-Executive Director: Jeremy Lewis Morgan
Independent Non-Executive Director: Mohammed Sohail Fazeli
Non-Executive Chairman: Andrew Richards
Non-Executive Dir: Alan Edward Smith

Contact Details

Address: Chesterford Research Park, Little Chesterford, Saffron Walden, United Kingdom, CB10 1XL
Phone: +44 (0)1223 426060
Website: https://arecor.com/

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BMWLM973

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

AREC Market Data

Currency UK Pounds
Share Price 43.00p
Change Today 1.50p
% Change 3.61 %
52 Week High 160.00
52 Week Low 38.00
Volume 12,395
Shares Issued 37.76m
Market Cap £16.24m

AREC Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
47.84% below the market average47.84% below the market average47.84% below the market average47.84% below the market average47.84% below the market average
6.38% above the sector average6.38% above the sector average6.38% above the sector average6.38% above the sector average6.38% above the sector average
Price Trend
91.59% below the market average91.59% below the market average91.59% below the market average91.59% below the market average91.59% below the market average
65.96% below the sector average65.96% below the sector average65.96% below the sector average65.96% below the sector average65.96% below the sector average
Income Not Available
Growth
41.88% above the market average41.88% above the market average41.88% above the market average41.88% above the market average41.88% above the market average
35.48% above the sector average35.48% above the sector average35.48% above the sector average35.48% above the sector average35.48% above the sector average

AREC Dividends

No dividends found

Trades for 28-May-2025

Time Volume / Share Price
16:28 7,500 @ 43.70p
13:12 1,700 @ 44.00p
09:21 255 @ 41.50p
08:45 28 @ 43.00p
08:37 745 @ 41.50p

AREC Key Personnel

CEO Sarah Jennifer Howell
CFO David Ellam

Top of Page